LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 60.44 | 771.67 | 1592 | 8530 | 0.1866 | 0.2323 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 60.44 | 771.67 | 1868 | 8530 | 0.2190 | 0.2905 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 62.66 | 771.67 | 1624 | 8978 | 0.1809 | 0.2339 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 62.66 | 771.67 | 1882 | 8978 | 0.2096 | 0.2864 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 64.88 | 771.67 | 1614 | 9447 | 0.1709 | 0.2265 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 64.88 | 771.67 | 1900 | 9447 | 0.2011 | 0.2832 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 67.10 | 771.67 | 1651 | 9800 | 0.1685 | 0.2305 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 67.10 | 771.67 | 1912 | 9800 | 0.1951 | 0.2808 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 69.32 | 771.67 | 1644 | 10212 | 0.1610 | 0.2251 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 69.32 | 771.67 | 1911 | 10212 | 0.1871 | 0.2755 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 71.54 | 771.67 | 1655 | 10532 | 0.1571 | 0.2243 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 71.54 | 771.67 | 1934 | 10532 | 0.1836 | 0.2759 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 73.76 | 771.67 | 1659 | 10851 | 0.1529 | 0.2223 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 73.76 | 771.67 | 1951 | 10851 | 0.1798 | 0.2753 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 76.02 | 771.67 | 1664 | 11106 | 0.1498 | 0.2211 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 76.02 | 771.67 | 1962 | 11106 | 0.1767 | 0.2745 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 78.25 | 771.67 | 1658 | 11367 | 0.1459 | 0.2178 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 78.25 | 771.67 | 1965 | 11367 | 0.1729 | 0.2723 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 80.48 | 771.67 | 1656 | 11685 | 0.1417 | 0.2150 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 80.48 | 771.67 | 1965 | 11685 | 0.1682 | 0.2692 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 82.69 | 771.67 | 1653 | 11974 | 0.1381 | 0.2124 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 82.69 | 771.67 | 2002 | 11974 | 0.1672 | 0.2725 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 84.92 | 771.67 | 1661 | 12266 | 0.1354 | 0.2118 | MN20160304_L01 | L03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 84.92 | 771.67 | 2002 | 12266 | 0.1632 | 0.2699 | MN20160304_L01 | L05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 87.14 | 771.67 | 1688 | 12592 | 0.1341 | 0.2145 | MN20160304_L01 | L03 |